Isavuconazole
9766-CL-0105
Phase 3 small_molecule completed
Quick answer
Isavuconazole for Candidiasis, Invasive is a Phase 3 program (small_molecule) at Astellas Pharma Inc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Astellas Pharma Inc
- Indication
- Candidiasis, Invasive
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed